全文获取类型
收费全文 | 2282篇 |
免费 | 102篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 72篇 |
妇产科学 | 28篇 |
基础医学 | 280篇 |
口腔科学 | 26篇 |
临床医学 | 130篇 |
内科学 | 484篇 |
皮肤病学 | 23篇 |
神经病学 | 269篇 |
特种医学 | 110篇 |
外科学 | 390篇 |
综合类 | 7篇 |
预防医学 | 67篇 |
眼科学 | 191篇 |
药学 | 64篇 |
中国医学 | 5篇 |
肿瘤学 | 261篇 |
出版年
2023年 | 29篇 |
2022年 | 32篇 |
2021年 | 62篇 |
2020年 | 37篇 |
2019年 | 48篇 |
2018年 | 51篇 |
2017年 | 40篇 |
2016年 | 57篇 |
2015年 | 55篇 |
2014年 | 64篇 |
2013年 | 79篇 |
2012年 | 135篇 |
2011年 | 135篇 |
2010年 | 81篇 |
2009年 | 64篇 |
2008年 | 132篇 |
2007年 | 107篇 |
2006年 | 128篇 |
2005年 | 142篇 |
2004年 | 134篇 |
2003年 | 115篇 |
2002年 | 123篇 |
2001年 | 36篇 |
2000年 | 33篇 |
1999年 | 53篇 |
1998年 | 30篇 |
1997年 | 36篇 |
1996年 | 23篇 |
1995年 | 15篇 |
1994年 | 37篇 |
1993年 | 23篇 |
1992年 | 21篇 |
1991年 | 27篇 |
1990年 | 25篇 |
1989年 | 26篇 |
1988年 | 24篇 |
1987年 | 19篇 |
1986年 | 8篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 5篇 |
1970年 | 6篇 |
排序方式: 共有2411条查询结果,搜索用时 31 毫秒
71.
72.
Norihiko Kanaguchi Naoki Narisawa Tatsuro Ito Yosuke Kinoshita Yasuka Kusumoto Osamu Shinozuka Hidenobu Senpuku 《BMC oral health》2012,12(1):1-8
Background
The aim of this investigation was to assess the state of oral health of patients with acute coronary syndrome (ACS) and to compare this with that of a provably healthy control group (H).Methods
33 patients who were receiving treatment as inpatients following acute myocardial infarction or unstable angina pectoris took part in the study (ACS-group). A healthy control group (H-group) made up of blood donors, was formed following matching for age, gender, and smoking habit with the study patient group. The dental investigation consisted of the dental status (DMF-T), a plaque-Index (PI), an assessment of gingival inflammation (GI) and periodontal situation (Periodontal Screening Index: PSR?/PSI), and attachment loss (AL). Statistical evaluation: t-test, Mann?CWhitney-test and chi- squared test (level of significance p?<?0.05).Results
The mean DMF-T of the ACS-group (18.7?±?6.8) and the H-group (19.4?±?5.1) showed no difference (p?=?0.7). Although, in the ACS-group the average loss of teeth (M-T: 8.4?±?5.2) was higher than in the H-group (M-T: 5.8?±?6.6) the difference was not significant (p?=?0.2). Whereas with the PI no difference between the two groups was found (p?=?0.9), the ACS-group showed significantly more signs of inflammation (GI) than the H-group (p?=?0.045). In the case of PSR?/PSI, there was no difference between the two groups (p?=?0.7). With regard to AL, no difference was revealed between ACS- and H-group (p?=?0.2).Conclusion
Although, the state of oral health of the ACS-group differed only insignificantly from that of control, patients with ACS showed more signs of gingival inflammation and a higher loss of teeth. 相似文献73.
74.
75.
76.
Kayakabe K Kuroiwa T Sakurai N Ikeuchi H Kadiombo AT Sakairi T Kaneko Y Maeshima A Hiromura K Nojima Y 《Rheumatology (Oxford, England)》2012,51(9):1639-1643
Objective. In RA, response to TNF blockers may be associated with a profile of cytokine production unique to each patient. This study sought to predict the response to biologic agents by examining pro-inflammatory cytokine synthesis in stimulated whole blood cultures (WBCs). Methods. We measured the concentration of TNF-α, IL-1β and IL-6 in supernatants of lipopolysaccharide (LPS)-stimulated WBCs obtained from RA patients (n?=?41) before anti-TNF therapy (infliximab, 13; etanercept, 26; and adalimumab, 2) and from healthy controls (n?=?12). At 24 weeks after biologics, whole bloods were again drawn from 14 of 41 patients. Response was defined by the European League Against Rheumatism response criteria after 24 weeks of therapy. Results. Among 41 patients, 32 were responders (good 14/moderate 18), while 9 were non-responders. All cytokines measured were significantly lower in RA patients than in controls. In RA, IL-1β production was lower in non-responders than in responders [median (interquartile range): 3.5 (1.5-9.4) vs 10.0 (5.1-93.1) pg/ml, P?=?0.048]. The area under the curve from a receiver operating characteristic curve analysis for the prediction of response using IL-1β was 0.717 (95% CI 0.520, 0.914). The sensitivity and specificity of IL-1β (cut-off value 4.84?pg/ml) was 78.1 and 77.8%, respectively. All cytokines were significantly higher 6 months later compared with their respective baseline. Conclusion. IL-1β measurement in LPS-stimulated WBC is useful to predict responsiveness to anti-TNF agents. Cytokine production capacities in LPS-stimulated WBCs are up-regulated by biologics. 相似文献
77.
Tatsuro Okamoto Takekazu Iwata Teruaki Mizobuchi Hidehisa Hoshino Yasumitsu Moriya Shigetoshi Yoshida Ichiro Yoshino 《Surgery today》2013,43(10):1123-1128
Purpose
The aim of this retrospective study was to evaluate the relevance of surgery in non-small cell lung cancer (NSCLC) patients with ipsilateral pulmonary metastases.Methods
The clinical records of 1,623 consecutive NSCLC patients who underwent surgery between 1990 and 2007 were retrospectively reviewed. Overall, 161 (9.9 %) and 21 (1.3 %) patients had additional nodules in the same lobe as the primary lesion (PM1) and additional nodules in the ipsilateral different lobe (PM2), respectively.Results
The 5-year survival rate was 54.4 % in the PM1 patients and 19.3 % in the PM2 patients (log-rank test: p = 0.001). Tumor size ≤3 cm, N0-1 status and surgical procedures less extensive than bilobectomy were identified as favorable prognostic factors in the PM1 patients. The 5-year survival rate in the PM1-N0-1 patients was 68.7 %, while that in the PM1-N2-3 patients was 29.1 % (p < 0.0001). Compared to the non-PM1 stage IIIA patients, the stage IIIA patients with PM1 disease (PM1-N1) tended to experience longer survival times (p = 0.06). Squamous cell types and bilobectomy or more extensive procedures were found to be unfavorable factors in the PM2 patients. The survival of the PM2 patients was significantly worse than that of the other T4 patients (p = 0.007).Conclusions
PM1 patients with N0-1 disease are good candidates for surgery, whereas PM2 patients do not appear to benefit from surgery. 相似文献78.
Young-Chang P. Arai Noboru Hatakeyama Makoto Nishihara Masahiko Ikeuchi Makoto Kurisuno Tatsunori Ikemoto 《Journal of anesthesia》2013,27(6):960-962
Most patients suffering from trigeminal neuralgia (TN) benefit from medical therapy, for example carbamazepin, gabapentin, and pregabalin, individually or in combination. Nonetheless, some patients experience severe and intractable pain despite such medication, or the medication eliminates their pain but they experience intolerable side effects sufficient to warrant discontinuation. Intravenous magnesium and lidocaine have been used for management of intractable neuropathic pain. We treated nine patients with TN by using an intravenous infusion of a combination of 1.2 g magnesium and 100 mg lidocaine for 1 hour, once a week for 3 weeks. All patients experienced sound pain relief after the combined intravenous infusion therapy. Two patients experienced short and mild dizziness after the therapy, but no severe side effects were reported. 相似文献
79.
80.
Tatsuro Misu Romana Höftberger Kazuo Fujihara Isabella Wimmer Yoshiki Takai Shuhei Nishiyama Ichiro Nakashima Hidehiko Konno Monika Bradl Ferenc Garzuly Yasuto Itoyama Masashi Aoki Hans Lassmann 《Acta neuropathologica》2013,125(6):815-827
Neuromyelitis optica (NMO) is an autoimmune disease targeting aquaporin 4 (AQP4), localized mainly at the astrocytic foot processes. Loss of AQP4 and glial fibrillary acidic protein (GFAP) was reported, but the pathological significance of astrocytopathy is still controversial. Here we show that active lesions in NMO display a wide spectrum of pathology even within a single tissue block of an individual patient. We have distinguished six different lesion types. The first reflects complement deposition at the surface of astrocytes, associated with granulocyte infiltration and astrocyte necrosis and followed by demyelination, global tissue destruction and the formation of cystic, necrotic lesions (lesion type 2). Such destructive lesions lead to Wallerian degeneration in lesion-related tracts (lesion type 3). Around active NMO lesions AQP4 may selectively be lost in the absence of aquaporin 1 (AQP1) loss or other structural damage (lesion type 4). Another pattern is characterized by clasmatodendrosis of astrocytes, defined by cytoplasmic swelling and vacuolation, beading and dissolution of their processes and nuclear alterations resembling apoptosis, which was associated with internalization of AQP4 and AQP1 and astrocyte apoptosis in the absence of complement activation. Such lesions give rise to extensive astrocyte loss, which may occur in part in the absence of any other tissue injury, such as demyelination or axonal degeneration (lesion type 5). Finally, lesions with a variable degree of astrocyte clasmatodendrosis are found, which show plaque-like primary demyelination that is associated with oligodendrocyte apoptosis, but with preservation of axons (lesion type 6). In active multiple sclerosis (MS) lesions astrocytes reveal changes of reactive protoplasmatic or fibrillary gliosis. Only in a subset of lesions, in patients with aggressive disease, loss of AQP4 is observed in the initial stage of their formation, which is associated with retraction of astrocyte processes in the absence of complement deposition, granulocyte infiltration or loss of AQP1 or astrocytes. Our data underline the primary assault of astrocytes in NMO lesions, but also indicate that different mechanisms of tissue injury operate in parallel in the same patient and even within the same lesion. 相似文献